Japanese Journal Of Clinical Oncology

Japanese Journal Of Clinical Oncology

日本临床肿瘤学杂志

  • 4区 中科院分区
  • Q3 JCR分区

高引用文章

文章名称 引用次数
Update version of the Japanese Guidelines for Gastric Cancer Screening 32
Chemotherapy for hepatocellular carcinoma: current status and future perspectives 32
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05) 30
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG ASCOT) 18
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset 17
Neuroblastoma 16
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study 16
Molecular-targeted therapies and precision medicine for endometrial cancer 12
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy 12
Immune checkpoint inhibitor-related myocarditis 12
The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer 12
Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma 10
New developments in systemic therapy for advanced biliary tract cancer 10
New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group 10
Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies 10
Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer 10
Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis 9
Proteasome inhibitors for multiple myeloma 9
Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma 9
New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer 9
Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies 9
Overview of current and future systemic therapy for metastatic renal cell carcinoma 9
Validation of the Integrated Palliative care Outcome Scale (IPOS) - Japanese Version 9
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients 8
Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma 8
PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy 8
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer 8
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610 8
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE) 8
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study 7
The dawn of robotic surgery in otolaryngology-head and neck surgery 7
Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer 7
Evidence-based cancer prevention recommendations for Japanese 7
Job resignation after cancer diagnosis among working survivors in Japan: timing, reasons and change of information needs over time 7
Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives 6
Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology 6
Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy 6
Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan 6
A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906 6
Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity 6
Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys 6
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan 6
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer 6
Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma 6
Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy 6
Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy 5
A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413) 5
Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women 5
Palliative pain relief and safety of percutaneous radiofrequency ablation combined with cement injection for bone metastasis 5
Green tea intake and colorectal cancer risk in Japan: the Takayama study 5